Acta Scientific Microbiology

Research ArticleVolume 1 Issue 6

Prevalence and Antifungal Susceptibility of Vaginal Candida albicans among Pregnant Women Attending Arua Regional Referral Hospital, Westnile Region of Uganda

Moses Ocan1*, Benjamin Tumushabe2, Hellen Nakawunde2, Jemmico Droma2 Geoffrey Waiswa2, Kalori Kirya2, Hannington Baluku2 and Wilson M Rwandembo4

1Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Uganda
2Department of Medical Laboratory Sciences, Mbarara University of Science and Technology, Uganda
3Department of Medical Microbiology, College of Health Sciences, Makerere University, Uganda
4Uganda Institute of Allied Health and Management Sciences, Uganda

*Corresponding Author: Moses Ocan, Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University.

Received: April 16, 2018; Published: May 11, 2018

Citation: Moses Ocan., et al. “Prevalence and Antifungal Susceptibility of Vaginal Candida albicans among Pregnant Women Attending Arua Regional Referral Hospital, Westnile Region of Uganda”. Acta Scientific Microbiology 1.6 (2018).


  Candida colonization’s occur globally with the risk and effects varying in different populations especially among the immunosuppressed and pregnant women. This study was thus conducted to establish the prevalence and antifungal susceptibility of Candida albicans among pregnant women seeking antenatal care at Arua Regional Referral Hospital (RRH) in West Nile region of Uganda. A cross-sectional study design was used and pregnant women attending antenatal care at Arua RRH recruited into the study using systematic random sampling. Interviewer administered questionnaire was used in data collection. High vaginal swab (HVS) samples were collected from each participant for laboratory analysis. Germ tube test was done to identify Candida albicans colonization of the vagina. Antifungal susceptibility of the Candida albicans isolates was determined using VITEK® 2 Compact system. Candida colonization was present in a third, 35.5% (89/251) of the pregnant women who participated in the study. The majority, 27.5% (69/251) of theCandida colonization were caused by Candida albicans. Non-candida albicans species were present in 7.9% (20/251) of the pregnant women. Most, 51.4% (129/251) of the participants were 26-35 years of age. The majority, 91.2% (129/251) of the pregnant women reported to be aware of Candida. Fluconazole and Flucytosine each had C. albicans isolates that showed intermediate susceptibility. While all the 69 C. albicans isolates were susceptible to voriconazole, caspofungin and mucafungin antifungal agents. From the study, C. albicans isolates from pregnant women seeking antenatal care in Arua RRH are susceptible to common antifungal agents.

Keywords: Antifungal Agents; Candida Albicans; Susceptibility; Prevalence; Arua Regional Referral Hospital

Copyright: © 2018 Moses Ocan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Member In

News and Events

  • Special Issue on Reviews
    Acta Scientific Journals has been started Special Issue on Reviews, researchers from world wide welcoming for submission of their reviews on any topic by on/ before August 30, 2019. Special Issue is going to be released on September 10, 2019
  • Submission Timeline
    Last date for submission of articles is August 30, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Papers of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US